Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy.

Riéli Elis Schulz Laura Izabel Lampert Bonzanini Gabriela Barbieri Ortigara Eloisa Barbieri Soldera Cristiane Cademartori Danesi Raquel Pippi Antoniazzi Kívia Linhares Ferrazzo

Published in: Journal of applied oral science : revista FOB (2021)

Hyposalivation is a highly prevalence late-onset side effect of radiotherapy in patients treated for head and neck cancer, with a greater chance of occurrence among those who received higher doses of radiation and those who ended therapy less than 22 months before our study. Concomitant chemotherapy and radiotherapy does not seem to increase the chances of hyposalivation compared to radiotherapy alone.

Keyphrases

locally advanced
early stage
late onset
radiation induced
radiation therapy
rectal cancer
risk factors
early onset
squamous cell carcinoma
risk assessment